Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

LBH589 Plus Decitabine for Myelodysplastic Syndromes or Acute Myeloid Leukemia

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT00691938
First received: June 4, 2008
Last updated: March 18, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2015
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)